Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants

BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in young children worldwide. Underlying health conditions, especially premature birth, chronic lung disease and congenital heart disease, predispose to severe RSV illness. The only means of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Dorothy, Sinilaite, Angela, Killikelly, April
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Health Agency of Canada 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324882/
https://www.ncbi.nlm.nih.gov/pubmed/37426290
http://dx.doi.org/10.14745/ccdr.v48i78a08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324882/
https://www.ncbi.nlm.nih.gov/pubmed/37426290
http://dx.doi.org/10.14745/ccdr.v48i78a08

Ejemplares similares